Health and Environmental Sciences Institute, Washington, DC, USA.
Albert Einstein College of Medicine, Bronx, NY, USA.
Regul Toxicol Pharmacol. 2020 Apr;112:104592. doi: 10.1016/j.yrtph.2020.104592. Epub 2020 Feb 1.
The need to develop new tools and increase capacity to test pharmaceuticals and other chemicals for potential adverse impacts on human health and the environment is an active area of development. Much of this activity was sparked by two reports from the US National Research Council (NRC) of the National Academies of Sciences, Toxicity Testing in the Twenty-first Century: A Vision and a Strategy (2007) and Science and Decisions: Advancing Risk Assessment (2009), both of which advocated for "science-informed decision-making" in the field of human health risk assessment. The response to these challenges for a "paradigm shift" toward using new approach methodologies (NAMS) for safety assessment has resulted in an explosion of initiatives by numerous organizations, but, for the most part, these have been carried out independently and are not coordinated in any meaningful way. To help remedy this situation, a framework that presents a consistent set of criteria, universal across initiatives, to evaluate a NAM's fit-for-purpose was developed by a multi-stakeholder group of industry, academic, and regulatory experts. The goal of this framework is to support greater consistency across existing and future initiatives by providing a structure to collect relevant information to build confidence that will accelerate, facilitate and encourage development of new NAMs that can ultimately be used within the appropriate regulatory contexts. In addition, this framework provides a systematic approach to evaluate the currently-available NAMs and determine their suitability for potential regulatory application. This 3-step evaluation framework along with the demonstrated application with case studies, will help build confidence in the scientific understanding of these methods and their value for chemical assessment and regulatory decision-making.
开发新工具和提高测试药物和其他化学品对人类健康和环境的潜在负面影响的能力的需求是一个活跃的发展领域。这项活动的大部分是由美国国家科学院的国家研究委员会(NRC)的两份报告引发的,《二十一世纪的毒理学测试:愿景与战略》(2007 年)和《科学与决策:推进风险评估》(2009 年),这两份报告都主张在人类健康风险评估领域进行“科学知情决策”。为了应对这些挑战,需要进行“范式转变”,采用新的方法来进行安全性评估,这导致了许多组织的倡议如雨后春笋般涌现,但在大多数情况下,这些倡议都是独立进行的,没有以任何有意义的方式进行协调。为了帮助改善这种情况,一个由工业、学术和监管专家组成的多方利益相关者小组制定了一个框架,为评估 NAM 的适用性提出了一套一致的标准,这些标准适用于所有的倡议。该框架的目标是通过提供一个收集相关信息的结构,为现有和未来的倡议提供更大的一致性,建立信心,从而加速、促进和鼓励开发新的 NAM,最终可以在适当的监管环境中使用。此外,该框架还提供了一种系统的方法来评估现有的 NAM,并确定它们是否适合潜在的监管应用。这个 3 步评估框架以及用案例研究进行的演示应用,将有助于建立对这些方法的科学理解及其在化学评估和监管决策中的价值的信心。